We are pleased to share a selection of papers from the first half of 2025, published in the journal Onco (ISSN: 2673-7523). Below is a list of high-quality papers that we believe you will find insightful and engaging.

1. “The Role of Therapeutic Vaccines in Cancer Immunotherapy”
by Constantin N. Baxevanis, Ourania E. Tsitsilonis, Maria Goulielmaki, Nikolaos Tsakirakis and Angelos D. Gritzapis
Onco 2025, 5(1), 11; https://doi.org/10.3390/onco5010011
Available online: https://www.mdpi.com/2673-7523/5/1/11

2. “Dual Approaches in Oncology: The Promise of siRNA and Chemotherapy Combinations in Cancer Therapies”
by Carolina Sousa and Mafalda Videira
Onco 2025, 5(1), 2; https://doi.org/10.3390/onco5010002
Available online: https://www.mdpi.com/2673-7523/5/1/2

3. “Targeting Pathways and Mechanisms in Gynecological Cancer with Antioxidant and Anti-Inflammatory Phytochemical Drugs”
by Sandhya Shukla, Arvind Kumar Shukla, Navin Ray, Adarsha Mahendra Upadhyay, Fowzul Islam Fahad, Sayan Deb Dutta, Arulkumar Nagappan and Raj Kumar Mongre
Onco 2025, 5(2), 24; https://doi.org/10.3390/onco5020024
Available online: https://www.mdpi.com/2673-7523/5/2/24

4. “Dormant Tumor Cells: Current Opportunities and Challenges in Clinical Practice”
by Emma Boydell, Maxime Borgeaud and Petros Tsantoulis
Onco 2025, 5(1), 3; https://doi.org/10.3390/onco5010003
Available online: https://www.mdpi.com/2673-7523/5/1/3

5. “Molecular Insight and Antioxidative Therapeutic Potentials of Plant-Derived Compounds in Breast Cancer Treatment”
by Sandhya Shukla, Arvind Kumar Shukla, Adarsha Mahendra Upadhyay, Navin Ray, Fowzul Islam Fahad, Arulkumar Nagappan, Sayan Deb Dutta and Raj Kumar Mongre
Onco 2025, 5(2), 27; https://doi.org/10.3390/onco5020027
Available online: https://www.mdpi.com/2673-7523/5/2/27

6. “HCC and Immunotherapy: The Potential Predictive Role of Gut Microbiota and Future Therapeutic Strategies”
by Carmelo Laface, Eleonora Lauricella, Girolamo Ranieri, Francesca Ambrogio, Felicia Maria Maselli, Elena Parlagreco, Giulia Bernardi, Elena Fea and Gianmauro Numico
Onco 2025, 5(1), 9; https://doi.org/10.3390/onco5010009
Available online: https://www.mdpi.com/2673-7523/5/1/9

7. “Perfusion Bioreactor Technology for Organoid and Tissue Culture: A Mini Review”
by Paola Avena, Lucia Zavaglia, Ivan Casaburi and Vincenzo Pezzi
Onco 2025, 5(2), 17; https://doi.org/10.3390/onco5020017
Available online: https://www.mdpi.com/2673-7523/5/2/17

8. “Advancing Bladder Cancer Biomarker Discovery: Integrating Mass Spectrometry and Molecular Imaging”
by Vadanasundari Vedarethinam
Onco 2025, 5(2), 13; https://doi.org/10.3390/onco5020013
Available online: https://www.mdpi.com/2673-7523/5/2/13

9. “Disparities in Immunotherapy Use Prior to First-Line Approval for Metastatic Hepatocellular Carcinoma in the United States”
by Manav Shah, Abdullah Khalid, Oliver Standring, Neda Amini, Lyudmyla Demyan, Shruti Koti, Emma Gazzara, Grace Wu, Nandan Vithlani, Danielle DePeralta et al.
Onco 2025, 5(1), 6; https://doi.org/10.3390/onco5010006
Available online: https://www.mdpi.com/2673-7523/5/1/6

10. “Adult B-Cell Acute Lymphoblastic Leukaemia Antigens and Enriched Pathways Identify New Targets for Therapy”
by Eithar Mohamed, Sara Goodman, Leah Cooksey, Daniel M. Fletcher, Olivia Dean, Viktoriya B. Boncheva, Ken I. Mills, Kim H. Orchard and Barbara-ann Guinn
Onco 2025, 5(2), 19; https://doi.org/10.3390/onco5020019
Available online: https://www.mdpi.com/2673-7523/5/2/19

You can view and submit relevant papers to Onco via https://www.mdpi.com/journal/onco.

Onco Editorial Office